TY - JOUR
T1 - H3K27ac acetylome signatures reveal the epigenomic reorganization in remodeled non-failing human hearts
AU - Pei, Jiayi
AU - Harakalova, Magdalena
AU - Treibel, Thomas A
AU - Lumbers, R Thomas
AU - Boukens, Bastiaan J
AU - Efimov, Igor R
AU - van Dinter, Jip T
AU - González, Arantxa
AU - López, Begoña
AU - El Azzouzi, Hamid
AU - van den Dungen, Noortje
AU - van Dijk, Christian G M
AU - Krebber, Merle M
AU - den Ruijter, Hester M
AU - Pasterkamp, Gerard
AU - Duncker, Dirk J
AU - Nieuwenhuis, Edward E S
AU - de Weger, Roel
AU - Huibers, Manon M
AU - Vink, Aryan
AU - Moore, Jason H
AU - Moon, James C
AU - Verhaar, Marianne C
AU - Kararigas, Georgios
AU - Mokry, Michal
AU - Asselbergs, Folkert W
AU - Cheng, Caroline
N1 - Publisher Copyright:
© 2020 The Author(s).
Copyright:
Copyright 2020 Elsevier B.V., All rights reserved.
PY - 2020/7/14
Y1 - 2020/7/14
N2 - Background: H3K27ac histone acetylome changes contribute to the phenotypic response in heart diseases, particularly in end-stage heart failure. However, such epigenetic alterations have not been systematically investigated in remodeled non-failing human hearts. Therefore, valuable insight into cardiac dysfunction in early remodeling is lacking. This study aimed to reveal the acetylation changes of chromatin regions in response to myocardial remodeling and their correlations to transcriptional changes of neighboring genes. Results: We detected chromatin regions with differential acetylation activity (DARs; P adj. < 0.05) between remodeled non-failing patient hearts and healthy donor hearts. The acetylation level of the chromatin region correlated with its RNA polymerase II occupancy level and the mRNA expression level of its adjacent gene per sample. Annotated genes from DARs were enriched in disease-related pathways, including fibrosis and cell metabolism regulation. DARs that change in the same direction have a tendency to cluster together, suggesting the well-reorganized chromatin architecture that facilitates the interactions of regulatory domains in response to myocardial remodeling. We further show the differences between the acetylation level and the mRNA expression level of cell-type-specific markers for cardiomyocytes and 11 non-myocyte cell types. Notably, we identified transcriptome factor (TF) binding motifs that were enriched in DARs and defined TFs that were predicted to bind to these motifs. We further showed 64 genes coding for these TFs that were differentially expressed in remodeled myocardium when compared with controls. Conclusions: Our study reveals extensive novel insight on myocardial remodeling at the DNA regulatory level. Differences between the acetylation level and the transcriptional level of cell-type-specific markers suggest additional mechanism(s) between acetylome and transcriptome. By integrating these two layers of epigenetic profiles, we further provide promising TF-encoding genes that could serve as master regulators of myocardial remodeling. Combined, our findings highlight the important role of chromatin regulatory signatures in understanding disease etiology.
AB - Background: H3K27ac histone acetylome changes contribute to the phenotypic response in heart diseases, particularly in end-stage heart failure. However, such epigenetic alterations have not been systematically investigated in remodeled non-failing human hearts. Therefore, valuable insight into cardiac dysfunction in early remodeling is lacking. This study aimed to reveal the acetylation changes of chromatin regions in response to myocardial remodeling and their correlations to transcriptional changes of neighboring genes. Results: We detected chromatin regions with differential acetylation activity (DARs; P adj. < 0.05) between remodeled non-failing patient hearts and healthy donor hearts. The acetylation level of the chromatin region correlated with its RNA polymerase II occupancy level and the mRNA expression level of its adjacent gene per sample. Annotated genes from DARs were enriched in disease-related pathways, including fibrosis and cell metabolism regulation. DARs that change in the same direction have a tendency to cluster together, suggesting the well-reorganized chromatin architecture that facilitates the interactions of regulatory domains in response to myocardial remodeling. We further show the differences between the acetylation level and the mRNA expression level of cell-type-specific markers for cardiomyocytes and 11 non-myocyte cell types. Notably, we identified transcriptome factor (TF) binding motifs that were enriched in DARs and defined TFs that were predicted to bind to these motifs. We further showed 64 genes coding for these TFs that were differentially expressed in remodeled myocardium when compared with controls. Conclusions: Our study reveals extensive novel insight on myocardial remodeling at the DNA regulatory level. Differences between the acetylation level and the transcriptional level of cell-type-specific markers suggest additional mechanism(s) between acetylome and transcriptome. By integrating these two layers of epigenetic profiles, we further provide promising TF-encoding genes that could serve as master regulators of myocardial remodeling. Combined, our findings highlight the important role of chromatin regulatory signatures in understanding disease etiology.
KW - Histone acetylation
KW - Myocardial remodeling
KW - Transcription factor
KW - Transcriptome
UR - http://www.scopus.com/inward/record.url?scp=85088043650&partnerID=8YFLogxK
U2 - 10.1186/s13148-020-00895-5
DO - 10.1186/s13148-020-00895-5
M3 - Article
C2 - 32664951
SN - 1868-7075
VL - 12
JO - Clinical Epigenetics
JF - Clinical Epigenetics
IS - 1
M1 - 106
ER -